Online Mindfulness-based Tic Reduction



Status:Active, not recruiting
Conditions:Neurology, Psychiatric, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:12/12/2018
Start Date:April 4, 2018
End Date:April 15, 2019

Use our guide to learn which trials are right for you!

Online Mindfulness-based Tic Reduction: Development and Testing (Phase One)

Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially
disabling neurobiological conditions. Although a range of pharmacological and psychosocial
treatments exists, a significant number of individuals either do not respond to the current
treatments, find them unacceptable, or cannot access them. Thus, it is essential that
researchers continue to pursue novel treatment approaches that can also be easily
disseminated to those in need.

Initial pilot data suggest that a mindfulness-based intervention may be beneficial for adults
with tic disorders. In the present study, the researchers aim to further develop this
mindfulness-based intervention, adapt it to be delivered online and pilot test the
intervention with a small group of participants. The data from this pilot test will inform a
subsequent randomized controlled trial comparing online mindfulness-based tic reduction to
online psychoeducation, relaxation, and supportive therapy.

The specific aim is to determine the feasibility and acceptability of Online
Mindfulness-based Tic Reduction in 6 adults with TS or PTD.

The researchers hypothesize that Online Mindfulness-based Tic Reduction will be feasible and
acceptable to adults with tic disorders as measured by participant satisfaction, qualitative
participant feedback, home practice compliance, dropout, and adverse events.


Inclusion Criteria:

1. 18 years of age or older,

2. possess a primary diagnosis of Tourette Syndrome or Persistent Tic Disorder,

3. fluent in English

4. residing in the United States,

5. either not be taking any tic suppressant medication or other psychotropic medication
or be at a stable dose for 8 weeks prior to the baseline assessment and throughout the
study

Exclusion Criteria:

1. be receiving concurrent psychotherapy for the duration of the study

2. have prior extensive experience with mindfulness and/or meditation and

3. cannot have another medical or psychological condition that would prevent the
individual from fully engaging in the study or require a higher level of care (e.g.,
suicidality).
We found this trial at
2
sites
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-4354
?
mi
from
Boston, MA
Click here to add this to my saved trials
Brunswick, Maine 04011
Phone: 207-798-4146
?
mi
from
Brunswick, ME
Click here to add this to my saved trials